Fierce Pharma April 5, 2024
Amid ongoing drug shortages and other headline-grabbing issues that fall under the FDA’s purview, the House Committee on Oversight and Accountability is putting the agency’s commissioner Robert Califf, M.D., on the hot seat.
In what could be a heated culmination of multiple concurrent House investigations, the committee is set to press Califf in an April 11 public hearing that will seek to “hold the commissioner accountable for what the FDA is doing to address ongoing crises,” committee Chairman James Comer, R-Kentucky, said in a press release.
Outside of the drug shortage probe, the hearing is set to explore the FDA’s response to the nationwide infant formula crisis, its regulation of tobacco and nicotine products as well as hemp and...
Today's Sponsors
Today's Sponsor